Daisy has spent 5 years’ evaluating healthcare businesses as both an adviser and investor. She is currently an Investment Associate at Kester Capital, a lower mid-market Private Equity firm with an investment focus on Healthcare, Technology and Data & Information. She has diligenced numerous healthcare investment opportunities and is also a board observer for Optibrium, a drug discovery software provider.
Daisy started her career at Strategy&, the strategic consulting arm of PwC, where she provided strategy support to clients in Healthcare, Life Sciences and Technology sectors. She advised private equity clients on potential acquisition targets and worked with corporate clients to achieve strategic priorities.